2012-22784. Draft Guidance for Industry on Self-Identification of Generic Drug Facilities, Sites, and Organizations; Availability; Correction
-
Start Preamble
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Notice; correction.
SUMMARY:
The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of Monday, August 27, 2012 (77 FR 51811). The document announced a draft guidance for industry entitled “Self-Identification of Generic Drug Facilities, Sites, and Organizations.” The document was published with an incorrect docket Start Printed Page 57095number. This document corrects that error.
Start Further InfoFOR FURTHER INFORMATION CONTACT:
Joyce Strong, Office of Policy, Food and Drug Administration, 10903 New Hampshire Ave. Bldg. 32, Rm. 3208, Silver Spring, MD 20993-0002, 301-796-9148.
End Further Info End Preamble Start Supplemental InformationSUPPLEMENTARY INFORMATION:
In FR Doc. 2012-20946, appearing on page 51811 in the Federal Register of Monday, August 27, 2012, the following correction is made:
1. On page 51811, in the third column, the docket number is corrected to read “FDA-2012-D-0881”.
Start SignatureDated: August 30, 2012.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2012-22784 Filed 9-14-12; 8:45 am]
BILLING CODE 4160-01-P
Document Information
- Comments Received:
- 0 Comments
- Published:
- 09/17/2012
- Department:
- Food and Drug Administration
- Entry Type:
- Notice
- Action:
- Notice; correction.
- Document Number:
- 2012-22784
- Pages:
- 57094-57095 (2 pages)
- Docket Numbers:
- Docket No. FDA-2012-D-0881
- PDF File:
- 2012-22784.pdf